• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
    • Cardiovascular
    • Orthopedics
  • Wall Street Beat
    • Funding Roundup
    • Mergers & Acquisitions
  • Podcasts & Webinars
    • Podcasts
    • Webinars
  • Resources
    • About MassDevice
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech 100 Index
    • Videos
    • Whitepapers
  • DeviceTalks Tuesdays
  • Coronavirus: Live updates

Medtronic

Zimmer Biomet narrowly avoids shareholder rebuke on executive pay

May 20, 2022 By Jim Hammerand

An unusually large share of Zimmer Biomet (NYSE:ZBH) investors voted against the orthopedics company’s pay packages for top executives at the annual shareholder meeting. About 54 percent of voting shareholders supported the pay packages of the company’s five top-paid executives at the May 13 meeting, according to results filed with the SEC yesterday. In 2021, nearly 93 […]

Filed Under: Blog, Business/Financial News, Featured, News Well, Orthopedics Tagged With: Medtronic, SEC, Zimmer Biomet, ZimVie

Study shows strong performance, improved outcomes with Medtronic Evolut TAVR

May 18, 2022 By Sean Whooley

Medtronic (NYSE:MDT) today announced positive results from a study of its Evolut transcatheter aortic valve replacement (TAVR) system. The Optimize PRO clinical study evaluated the self-expanding, supra-annular Evolut PRO and PRO+ TAVR platforms. Medtronic’s CoreValve Evolut R, CorValve Evolut PRO and Evolut Pro+ systems are indicated for the relief of aortic stenosis in patients with […]

Filed Under: Cardiac Implants, Cardiovascular, Clinical Trials, Featured, News Well, Replacement Heart Valves, Structural Heart Tagged With: Medtronic, tavr

Medtronic’s Resolute Onyx drug-eluting stent demonstrates strong safety, efficacy

May 18, 2022 By Sean Whooley

Data presented today at the EuroPCR 2022 event supported the use of the Medtronic (NYSE:MDT) Resolute Onyx drug-eluting stent. University of Padua Medical School Head of Interventional Cardiology Dr. Giuseppe Tarantini presented late-breaking clinical trial results from the investigator-initiated, Medtronic-funded ROLEX (Revascularization Of LEft Main With Resolute onyX) registry. ROLEX, the largest real-world, multicenter prospective study, observed […]

Filed Under: Cardiac Implants, Cardiovascular, Clinical Trials, Drug-Device Combinations, Drug-Eluting Stents, Featured, Implants, News Well, Stents, Structural Heart, Vascular Tagged With: Medtronic

Medtronic’s renal denervation system demonstrates better blood pressure control, time in range

May 17, 2022 By Sean Whooley

Medtronic (NYSE:MDT) announced today that new data supports the use of its Symplicity Spyral renal denervation (RDN) system. As part of the medtech giant’s Spyral HTN global clinical program, three-year data from the Spyral HTN-ON MED and GSR-Define trials were presented at EuroPCR 2022 as late-breaking clinical trials demonstrating the benefit of the Symplicity blood […]

Filed Under: Blood Management, Cardiovascular, Clinical Trials, Featured, News Well Tagged With: Medtronic, renal denervation

The road to a robot: Medtronic’s development process for its Hugo RAS system

May 16, 2022 By Sean Whooley

Elephants are the perfect analogy for surgical robotics, Medtronic (NYSE:MDT) VP of Marketing for Surgical Robotics Mike Stow says. Speaking on the “Road to a robot: Designing technology to address unmet needs & barriers” panel at DeviceTalks Boston last week, Stow explained that elephants are big, taking up a lot of space and that they […]

Filed Under: Business/Financial News, Featured, Food & Drug Administration (FDA), Health Technology, News Well, Regulatory/Compliance, Robotics, Surgical, Urology Tagged With: Covidien, DeviceTalks Boston, Medtronic, Robotic Surgery, surgical robot

FDA approves Medtronic’s Onyx Frontier drug-eluting coronary stent

May 13, 2022 By Sean Whooley

Medtronic (NYSE:MDT) announced today that it received FDA approval for its Onyx Frontier drug-eluting stent (DES). Onyx Frontier, the latest iteration of Medtronic’s Resolute DES family, was designed to leverage the same stent platform as Resolute with an enhanced delivery system for improving deliverability and increasing acute performance, even in the most challenging of cases. Get […]

Filed Under: Cardiac Implants, Cardiovascular, Catheters, Drug-Device Combinations, Drug-Eluting Stents, Featured, Food & Drug Administration (FDA), Regulatory/Compliance, Stents, Structural Heart, Vascular Tagged With: FDA, Medtronic

Medtronic completes Intersect ENT acquisition

May 13, 2022 By Sean Whooley

Medtronic (NYSE:MDT) announced that it completed its previously announced $1.1 billion acquisition of Intersect ENT (Nasdaq:XENT). Fridley, Minnesota-based Medtronic announced in August 2021 that it would acquire all outstanding shares of the Menlo Park, California-based sinus implant maker for $28.25 per share in an all-cash transaction. As a result of the transaction, Medtronic acquires Intersect […]

Filed Under: Business/Financial News, Drug-Device Combinations, Featured, Implants, Mergers & Acquisitions, News Well, Otolaryngology/Ear, Nose & Throat (ENT) Tagged With: Intersect ENT, Medtronic

Medtronic must sell Intersect ENT subsidiary to satisfy FTC concerns

May 12, 2022 By Chris Newmarker

The Federal Trade Commission has issued a proposed order to require Medtronic (NYSE:MDT) to sell a subsidiary of Intersect ENT within 10 days of completing its $1.1 billion acquisition of Intersect ENT. The commission announced May 10 that it voted 4-0 to issue its complaint and accept the proposed consent order for public comment. Under […]

Filed Under: Business/Financial News, Featured, Legal News, Mergers & Acquisitions, News Well Tagged With: antitrust, Federal Trade Commission (FTC), Hemostasis, Intersect ENT, Medtronic

Medtronic’s VC leader discusses risk, returns, strategy and an ‘ugly truth’

May 10, 2022 By Jim Hammerand

A panel of medtech investors convened today for DeviceTalks Boston included David Neustaedter, vice president of venture capital at Medtronic (NYSE: MDT). He’s spent 14 years in the role, including as director of venture capital at Covidien before Medtronic acquired the company (read more in his DeviceTalks speaker bio). Medtronic has more than $500 million in […]

Filed Under: Blog, Business/Financial News, Featured Tagged With: DeviceTalks Boston, Medtronic, VC, venture capital

Manufacturing matchmaker Fictiv raises $100M for supply chain push

May 5, 2022 By Jim Hammerand

Fictiv has closed a $100 million Series E funding round, the on-demand manufacturing technology company said today. Fictiv focuses on “helping companies produce better products,” co-founder and CEO Dave Evans said, with three main offerings: new product development, engineer-to-order products, and maintenance, repair and operations (MRO). But the company doesn’t actually own any manufacturing equipment. […]

Filed Under: Blog, Business/Financial News, Contract Manufacturing, Featured, Funding Roundup, News Well, Outsourcing, Robotics Tagged With: Fictiv, Intuitive Surgical, Johnson & Johnson, Medtronic

CGMs, insulin pumps and more: the biggest diabetes news to come out of ATTD 2022

May 3, 2022 By Sean Whooley

All kinds of technologies were on display at the Advanced Technologies & Treatments for Diabetes (ATTD) conference in Barcelona last week. From continuous glucose monitoring (CGM) to automated insulin delivery, with plenty in between, a number of companies shared positive data for their diabetes offerings. Here are five of the biggest stories to come out […]

Filed Under: Business/Financial News, Clinical Trials, Diabetes, Digital Health, Drug Pumps, Drug-Device Combinations, Featured, Health Technology, Patient Monitoring, Software / IT Tagged With: Abbott, Ascensia Diabetes Care, Beta Bionics, CamDiab, DarioHealth Corp, Dexcom, Diabeloop, Insulet, Medtronic, One Drop, Tandem Diabetes Care, Walmart, Welldoc, Ypsomed

  • Go to page 1
  • Go to page 2
  • Go to page 3
  • Interim pages omitted …
  • Go to page 125
  • Go to Next Page »

Primary Sidebar

DeviceTalks Weekly

May 20, 2022
DeviceTalks Boston Post-Game – Editors’ Top Moments, Insulet’s Eric Benjamin on future of Omnipod 5
See More >

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Need Medtech news in a minute?
We Deliver!

MassDevice Enewsletters get you caught up on all the mission critical news you need in med tech. Sign up today.

MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World

Device Talks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our Device Talks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us
Add us on Facebook Follow us on Twitter Connect with us on LinkedIn Follow us on YouTube

Copyright © 2022 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Advertise | Privacy Policy | RSS